JN.1 most common COVID variant in US by Dec 23?
$3,923 Vol.
Rules
This market will resolve to "Yes" if the JN.1 variant of SARS-CoV-2 is responsible for the most COVID-19 cases by proportion in the United States according to CDC's Nowcast at the time of its next release (after 12/9/23). Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.
The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.
Created At: Dec 19, 2023, 5:57 PM UTC
Volume
$3,923End Date
Dec 23, 2023Created At
Dec 19, 2023, 5:57 PM UTCResolution Source
https://covid.cdc.gov/covid-data-tracker/#variant-proportionsResolver
0x6A9D22261...Outcome proposed: Yes
No dispute
Final outcome: Yes
$3,923 Vol.
JN.1 most common COVID variant in US by Dec 23?
About
This market will resolve to "Yes" if the JN.1 variant of SARS-CoV-2 is responsible for the most COVID-19 cases by proportion in the United States according to CDC's Nowcast at the time of its next release (after 12/9/23). Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.
The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.
Volume
$3,923End Date
Dec 23, 2023Created At
Dec 19, 2023, 5:57 PM UTCResolution Source
https://covid.cdc.gov/covid-data-tracker/#variant-proportionsResolver
0x6A9D22261...Outcome proposed: Yes
No dispute
Final outcome: Yes
Beware of external links.
Beware of external links.
Beware of external links.
Beware of external links.